China Universal Asset Management Co., Ltd. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72
+53.2%
2,263
+95.9%
0.02%
+40.0%
Q2 2023$47
+6.8%
1,155
-3.1%
0.02%0.0%
Q1 2023$44
+33.3%
1,192
+24.9%
0.02%
+15.4%
Q4 2022$33
-99.9%
954
+10.2%
0.01%
-35.0%
Q3 2022$48,000
+500.0%
866
+462.3%
0.02%
+566.7%
Q2 2022$8,000
-27.3%
1540.0%0.00%
-25.0%
Q1 2022$11,000
-38.9%
1540.0%0.00%0.0%
Q4 2021$18,0001540.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders